Related references
Note: Only part of the references are listed.Oxycodone-induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition
Rob Hill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice
Silvia Castany et al.
SCIENTIFIC REPORTS (2018)
Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers
Azzurra Stefanucci et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain
Wei Lei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia
Gregory Corder et al.
NATURE MEDICINE (2017)
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists
Shaness A. Grenald et al.
NEUROPHARMACOLOGY (2017)
Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics
Cullen L. Schmid et al.
CELL (2017)
The Prescription Opioid Addiction Treatment Study: What have we learned
Roger D. Weiss et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Gaining in pan-affinity towards sigma 1 and sigma 2 receptors. SAR studies on arylalkylamines
Daniela Rossi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Structure-Activity Relationships of [des-Arg7]Dynorphin A Analogues at the κ Opioid Receptor
Cyf N. Ramos-Colon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
A randomized, phase 2 study investigating TRV130, a biased ligand of the mu-opioid receptor, for the intravenous treatment of acute pain
Eugene R. Viscusi et al.
PAIN (2016)
Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice
Pao-Pao Yang et al.
PHARMACOLOGICAL RESEARCH (2016)
BU08073 a buprenorphine analogue with partial agonist activity at mu-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice
T. V. Khroyan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Stabilization of morphine tolerance with long-term dosing: Association with selective upregulation of mu-opioid receptor splice variant mRNAs
Jin Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Selectively Promiscuous Opioid Ligands: Discovery of High Affinity/Low Efficacy Opioid Ligands with Substantial Nociceptin Opioid Peptide Receptor Affinity
Vinod Kumar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The Pharmacologic and Clinical Effects of Medical Cannabis
Laura M. Borgelt et al.
PHARMACOTHERAPY (2013)
The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics
Kirsten M. Raehal et al.
NEUROPHARMACOLOGY (2011)
Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs
Donna A. Volpe et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Functional activation of monoamine transporters by luteolin and apigenin isolated from the fruit of Perilla frutescens (L.) Britt
Gang Zhao et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews
Kurt Kroenke et al.
GENERAL HOSPITAL PSYCHIATRY (2009)
Dosing protocol and analgesic efficacy determine opioid tolerance in the mouse
Priyanka A. Madia et al.
PSYCHOPHARMACOLOGY (2009)
Hydromorphone efficacy and treatment protocol impact on tolerance and μ-opioid receptor regulation
Priyank Kumar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Long-acting κ opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase
Michael R. Bruchas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
(-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (Tapentadol HCl):: a novel μ-opioid receptor agonist norepinephrine Reuptake inhibitor with broad-spectrum analgesic properties
Thomas M. Tzschentke et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of μ-opioid receptors and dynamin-2
Mohit Pawar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Pharmacological aspects of the effects of tramadol on G-protein coupled receptors
Kouichiro Minami et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
Discovery of high-affinity ligands of σ1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening
C Laggner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Morphine side effects in beta-arrestin 2 knockout mice
KM Raehal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Multiple opiate receptors: deja vu all over again
GW Pasternak
NEUROPHARMACOLOGY (2004)
Opioid therapy for chronic pain
JC Ballantyne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography
SM Learned-Coughlin et al.
BIOLOGICAL PSYCHIATRY (2003)
Understanding the molecular mechanism of sigma-1 receptors: Towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction
TP Su et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Dynorphin-independent spinal cannabinoid antinociception
LR Gardell et al.
PAIN (2002)
Activation profiles of opioid ligands in HEK cells expressing δ opioid receptors
Parham Gharagozlou et al.
BMC NEUROSCIENCE (2002)
Acute opioid receptor desensitization and tolerance: Is there a link?
S Borgland
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2001)
Share Paper
